Activation of ventral hippocampal CB1 receptors inhibits ketamine-induced anxiogenic-like behavior: Alteration of BDNF/c-Fos levels in the mouse hippocampus
出版年份 2023 全文链接
标题
Activation of ventral hippocampal CB1 receptors inhibits ketamine-induced anxiogenic-like behavior: Alteration of BDNF/c-Fos levels in the mouse hippocampus
作者
关键词
-
出版物
BRAIN RESEARCH
Volume 1810, Issue -, Pages 148378
出版商
Elsevier BV
发表日期
2023-04-28
DOI
10.1016/j.brainres.2023.148378
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Role of 5-HT1A receptors in the ventral hippocampus in the regulation of anxiety- and panic-related defensive behaviors in rats
- (2021) Paloma Molina Hernandes et al. BEHAVIOURAL BRAIN RESEARCH
- Pharmacodynamic elucidation of glutamate & dopamine in ketamine-induced anaesthesia
- (2020) Li-Hua Sun et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Ketamine effects on anxiety and fear-related behaviors: Current literature evidence and new findings
- (2020) Gabriela P. Silote et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Effects of Ketamine on Learning and Memory in the Hippocampus of Rats through ERK, CREB, and Arc
- (2020) Mingxian Shi et al. Brain Sciences
- Ketamine-induced antidepressant like effects in mice: A possible involvement of cannabinoid system
- (2019) Fatemeh Khakpai et al. BIOMEDICINE & PHARMACOTHERAPY
- Ketamine induces central antinociception mediated by endogenous cannabinoids and activation of CB1 receptors
- (2019) Daniela da Fonseca Pacheco et al. NEUROSCIENCE LETTERS
- Elevation of endocannabinoids in the brain by synthetic cannabinoid JWH-018: mechanism and effect on learning and memory
- (2019) Ren-shi Li et al. Scientific Reports
- The role of cannabis in treating anxiety
- (2019) Michael Van Ameringen et al. CURRENT OPINION IN PSYCHIATRY
- The Involvement of the Endocannabinoid System in the Peripheral Antinociceptive Action of Ketamine
- (2018) Renata C.M. Ferreira et al. JOURNAL OF PAIN
- Anxiolytic effects of ascorbic acid and ketamine in mice
- (2018) Daiane B. Fraga et al. JOURNAL OF PSYCHIATRIC RESEARCH
- The anxiolytic effects of cannabidiol in chronically stressed mice are mediated by the endocannabinoid system: Role of neurogenesis and dendritic remodeling
- (2018) Manoela V. Fogaça et al. NEUROPHARMACOLOGY
- The effects of ketamine on sexual behavior, anxiety, and locomotion in female rats
- (2018) Fay A. Guarraci et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
- (2018) Spencer L James et al. LANCET
- What is the mechanism of Ketamine's rapid-onset antidepressant effect? A concise overview of the surprisingly large number of possibilities
- (2017) S. E. Strasburger et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Effects of ketamine on the unconditioned and conditioned locomotor activity of preadolescent and adolescent rats: impact of age, sex, and drug dose
- (2017) Sanders A. McDougall et al. PSYCHOPHARMACOLOGY
- The effects of low-dose ketamine on the prefrontal cortex and amygdala in treatment-resistant depression: A randomized controlled study
- (2016) Cheng-Ta Li et al. HUMAN BRAIN MAPPING
- Ketamine administration reduces amygdalo-hippocampal reactivity to emotional stimulation
- (2016) Milan Scheidegger et al. HUMAN BRAIN MAPPING
- Ketamine alone or combined with midazolam or dexmedetomidine does not affect anxiety-like behaviours and memory in adult Wistar rats
- (2016) Ana Magalhães et al. LABORATORY ANIMALS
- The orexin-1 receptor antagonist SB-334867 decreases anxiety-like behavior and c-Fos expression in the hypothalamus of rats exposed to cat odor
- (2015) M.W. Vanderhaven et al. BEHAVIOURAL BRAIN RESEARCH
- Dissecting the cannabinergic control of behavior: Thewherematters
- (2015) Arnau Busquets-Garcia et al. BIOESSAYS
- Cannabidiol as a Potential Treatment for Anxiety Disorders
- (2015) Esther M. Blessing et al. Neurotherapeutics
- Cannabinoid CB1 receptors in the dorsal hippocampus and prelimbic medial prefrontal cortex modulate anxiety-like behavior in rats: Additional evidence
- (2015) Sabrina F. Lisboa et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- The nitric oxide donor sodium nitroprusside attenuates recognition memory deficits and social withdrawal produced by the NMDA receptor antagonist ketamine and induces anxiolytic-like behaviour in rats
- (2015) Aikaterini Trevlopoulou et al. PSYCHOPHARMACOLOGY
- A positive association between anxiety disorders and cannabis use or cannabis use disorders in the general population- a meta-analysis of 31 studies
- (2014) Karina Karolina Kedzior et al. BMC Psychiatry
- The cannabinoid receptor 1 associates with NMDA receptors to produce glutamatergic hypofunction: implications in psychosis and schizophrenia
- (2014) Pilar Sánchez-Blázquez et al. Frontiers in Pharmacology
- Effects of chronic ketamine use on frontal and medial temporal cognition
- (2013) Kahlen W.S. Chan et al. ADDICTIVE BEHAVIORS
- Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial
- (2013) James W. Murrough et al. AMERICAN JOURNAL OF PSYCHIATRY
- Cannabinoid Receptors Couple to NMDA Receptors to Reduce the Production of NO and the Mobilization of Zinc Induced by Glutamate
- (2013) Pilar Sánchez-Blázquez et al. ANTIOXIDANTS & REDOX SIGNALING
- Ketamine increases striatal dopamine release and hyperlocomotion in adult rats after postnatal functional blockade of the prefrontal cortex
- (2013) Y. Usun et al. BEHAVIOURAL BRAIN RESEARCH
- Ketamine Pharmacology: An Update (Pharmacodynamics and Molecular Aspects, Recent Findings)
- (2013) Georges Mion et al. CNS Neuroscience & Therapeutics
- Ketamine-induced antidepressant effects are associated with AMPA receptors-mediated upregulation of mTOR and BDNF in rat hippocampus and prefrontal cortex
- (2013) W. Zhou et al. EUROPEAN PSYCHIATRY
- HINT1 protein cooperates with cannabinoid 1 receptor to negatively regulate glutamate NMDA receptor activity
- (2013) Ana Vicente-Sánchez et al. Molecular Brain
- Interactions between NMDA and dopamine receptors: A potential therapeutic target
- (2012) Min Wang et al. BRAIN RESEARCH
- Chronic Ketamine Administration Modulates Midbrain Dopamine System in Mice
- (2012) Sijie Tan et al. PLoS One
- Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression
- (2011) Hiroyuki Koike et al. BEHAVIOURAL BRAIN RESEARCH
- The endocannabinoid system in anxiety, fear memory and habituation
- (2011) S Ruehle et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Cannabinoid receptor activation modifies NMDA receptor mediated release of intracellular calcium: Implications for endocannabinoid control of hippocampal neural plasticity
- (2011) Robert E. Hampson et al. NEUROPHARMACOLOGY
- Behavioral alterations and pro-oxidant effect of a single ketamine administration to mice
- (2010) Francisca Charliane Carlos da Silva et al. BRAIN RESEARCH BULLETIN
- Anxiolytic-like effect induced by the cannabinoid CB1 receptor agonist, arachydonilcyclopropylamide (ACPA), in the rat amygdala is mediated through the D1 and D2 dopaminergic systems
- (2010) Mohammad Reza Zarrindast et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The interplay of cannabinoid and NMDA glutamate receptor systems in humans: Preliminary evidence of interactive effects of cannabidiol and ketamine in healthy human subjects
- (2010) Jaime E.C. Hallak et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Hippocampal NMDA receptors and anxiety: At the interface between cognition and emotion
- (2009) Christopher Barkus et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Cannabis and anxiety: a critical review of the evidence
- (2009) José Alexandre Crippa et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Brain-Derived Neurotrophic Factor and Initial Antidepressant Response to anN-Methyl-D-Aspartate Antagonist
- (2009) Rodrigo Machado-Vieira et al. JOURNAL OF CLINICAL PSYCHIATRY
- Signaling Pathways from Cannabinoid Receptor-1 Activation to Inhibition of N-Methyl-D-Aspartic Acid Mediated Calcium Influx and Neurotoxicity in Dorsal Root Ganglion Neurons
- (2009) Q. Liu et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Anxiolytic- and antidepressant-like properties of ketamine in behavioral and neurophysiological animal models
- (2009) E. Engin et al. NEUROSCIENCE
- Ketamine treatment reverses behavioral and physiological alterations induced by chronic mild stress in rats
- (2009) Lêda S.B. Garcia et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- The pharmacology of the endocannabinoid system: functional and structural interactions with other neurotransmitter systems and their repercussions in behavioral addiction
- (2008) José Antonio López-Moreno et al. ADDICTION BIOLOGY
- Cannabinoid CB1 receptor antagonist rimonabant attenuates reinstatement of ketamine conditioned place preference in rats
- (2008) Fangqiong Li et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Cellular Mechanisms Underlying the Antidepressant Effects of Ketamine: Role of α-Amino-3-Hydroxy-5-Methylisoxazole-4-Propionic Acid Receptors
- (2007) Sungho Maeng et al. BIOLOGICAL PSYCHIATRY
- CB1 receptor stimulation in specific brain areas differently modulate anxiety-related behaviour
- (2007) T. Rubino et al. NEUROPHARMACOLOGY
- Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus
- (2007) Lêda S.B. Garcia et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started